TY  - JOUR
AB  - For a better understanding of the pathogenesis of complex, inflammatory skin diseases, molecular signatures represent an important tool. However until today, the establishment of reliable signatures for psoriasis and eczema was hampered by the high inter-individual differences in the patient cohorts investigated. Quaranta et al.1 report in a recently published work in Science Translational Medicine about a unique patient cohort that overcomes these known obstacles - patients affected by psoriasis and eczema simultaneously1. With this cohort, the authors could establish clear signatures for both diseases and underline the importance of the immune system in the pathogenesis. These signatures also allowed to establish a classifier that dissects psoriasis from eczema reliably - An important step for patients with uncertain diagnosis and a first step into personalized medicine in inflammatory skin diseases.
AU  - Eyerich, S.
C1  - 43869
C2  - 36753
SP  - 24-30
TI  - Molekulare Signaturen zur besseren Unterscheidung : Psoriasis und Ekzem - was wir von doppelt betroffenen Patienten lernen können.
JO  - Haut
VL  - 26
IS  - 1
PY  - 2015
SN  - 0938-2216
ER  - 

TY  - JOUR
AU  - Standl, M.
AU  - Weidinger, S.
C1  - 47830
C2  - 39523
SP  - 345-346
TI  - Weltweit größte genetische Studie zu Neurodermitis.
JO  - Haut
VL  - 26
IS  - 6
PY  - 2015
SN  - 0938-2216
ER  -